Used in pharmaceutical research as a key intermediate in the synthesis of centrally acting muscle relaxants and neuroactive agents. Its structure supports binding to CNS receptors, making it valuable in developing treatments for neurological disorders such as anxiety, epilepsy, and spasticity. The compound's ability to cross the blood-brain barrier enhances its utility in targeting brain-specific pathways. It is also explored for use in radiolabeled forms for neuroimaging studies.